Search Results 1-10 of 17295 for GLP-1 therapy

  1. Diabetes drugs and weight loss - Mayo Clinic

    The first group is glucagon-like peptide 1 (GLP-1) agonists. ... 1 works in the body. ... Glucagon-like peptide 1 receptor agonists for the treatment of type 2 ...

  2. Mayo Clinic Minute: Using combined therapy to treat obesity

    Using combined therapy to treat obesity, combining bariatric surgery, also called metabolic surgery, with GLP-1 medications. Learn more.

  3. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...

  4. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    "The magnitude of this difference warrants future studies that could help clarify how GLP-1-based obesity medications and menopausal hormone therapy may ...

  5. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are cornerstone therapies for type 2 diabetes, obesity and cardiovascular health.

  6. Contribution of GLP-1 Receptor - Mayo Clinic

    Results from this study may help us identify therapeutic pathways to prevent or reverse type 2 diabetes mellitus. Participation eligibility. Participant ...

  7. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... 1 (GLP-1) receptor agonist. Semaglutide injection is also used together with ... treatment for you. If both medicines are prescribed together, your doctor may ...

  8. Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) - Mayo Clinic

    The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure ...

  9. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information ...

  10. A Study Of GLP-1–Based Therapies On Sexual Health In Postmenopausal Women - Mayo Clinic

    A Study Of GLP-1–Based Therapies On Sexual Health In Postmenopausal Women · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...